UP Health System – Marquette is now offering advanced imaging technology for cancer patients. This new PET/CT system helps doctors better understand, track, and treat cancer. With this new equipment, the most sensitive cancer imaging system on the market, UPHS – Marquette clinicians can pinpoint small tumors and lesions due to the high sensitivity of the PET technology. This product aims to continuously improve diagnostic confidence for referring physicians and patients. Patients can also expect to be scanned quickly and efficiently, which enables both half the PET dose and half the scan time. Fast scans are helpful for elderly or sick patients that cannot hold still for a long time.
“At UPHS – Marquette, we constantly seek new technologies and methods that help us tackle cancer early,” said Renee Brundin, Ph.D., MBA, CNMT, Director, Imaging and Invasive Services at UPHS – Marquette. “This is why we’ve invested in this new technology, which will help us better examine, monitor, and care for our patients.
The system is primarily used to scan cancer patients and uses intelligent quantitation (IQ) to quantify changes in tumors and diseases. Quantitation can help clinicians detect cancer early and understand whether patients are responding to their current treatments. With those insights, clinicians can optimize treatment paths and tailor the appropriate therapy regimens according to patients’ unique needs.
Cancer clinicians no longer have to choose between high image quality and quantitative measurements that help them diagnose and monitor tumors. This technology improves both image quality and quantitative accuracy – allowing clinicians to make a more confident cancer diagnosis and obtain measurements that can help to track treatment progress.
The system can correct for some patient motion inside the scanner and is mobile-ready, so it can be accessible to more patients in more places. The system is long-term and is designed so that additional PET detector rings (maximum of 5) can be added to improving coverage and providing additional flexibility around dose and acquisition time, demonstrating UPHS – Marquette’s continued commitment to providing superior cancer care now and in the future.